Abaxis Inc (NASDAQ:ABAX)

62.11
Delayed Data
As of Mar 04
 +0.32 / +0.52%
Today’s Change
36.77
Today|||52-Week Range
66.05
+9.29%
Year-to-Date
Bioscrip Q4 Loss Wider than Expected, Revenues Up Y/Y - Analyst Blog
Mar 04 / Zacks.com
Wright Medical Q4 Loss Narrower than Expected, Revenues Lag - Analyst Blog
Feb 26 / Zacks.com
NxStage Medical (NXTM) Q4 Loss Narrower than Expected - Analyst Blog
Mar 04 / Zacks.com
3 Stocks With Upcoming Ex-Dividend Dates: ABAX, TSRA, OUTR
Feb 26 / TheStreet.com
Boston Scientific to Buy Endo International's Urology Business - Analyst Blog
Mar 03 / Zacks.com
Are You Considering Abaxis (ABAX) Post Solid Q3 Earnings? - Analyst Blog
Feb 25 / Zacks.com
ICON (ICLR) Posts Stellar Q4 Earnings, Revenues Rise Y/Y - Analyst Blog
Mar 03 / Zacks.com
Merit Medical (MMSI) Q4 Earnings, Sales Top Estimates; Up Y/Y - Analyst Blog
Feb 25 / Zacks.com
Air Methods (AIRM) Q4 Earnings Top Estimates, Surge Y/Y - Analyst Blog
Mar 03 / Zacks.com
Medtronic Adds Advanced Uro-Solutions to Neuromodulation - Analyst Blog
Feb 24 / Zacks.com
INSYS Therapeutics Slumps: INSY Falls 7% in Session - Tale of the Tape
Mar 03 / Zacks.com
ResMed Upped to Hold on Several Growth Initiatives - Analyst Blog
Feb 24 / Zacks.com
Omnicare (OCR) Q4 Earnings, Sales Top Estimates; Rise Y/Y - Analyst Blog
Mar 02 / Zacks.com
What Makes Agios Pharmaceuticals (AGIO) a Strong Sell? - Tale of the Tape
Feb 24 / Zacks.com
Globus Medical (GMED) Beats on Q4 Earnings, Sales in Line - Analyst Blog
Mar 02 / Zacks.com
Medtronic's Artificial Pancreas Technology: Key to Diabetes Cure? - Analyst Blog
Feb 23 / Zacks.com
Allscripts (MDRX) Tops Q4 Earnings by a Penny, Revenues Lag - Analyst Blog
Feb 27 / Zacks.com
Zimmer Upbeat on Biomet Takeover, Americas Sales Disappoint - Analyst Blog
Feb 23 / Zacks.com
Walgreens Boots: Market Optimism on Merger Makes It a Buy - Analyst Blog
Feb 26 / Zacks.com
Bruker Beats Q4 Earnings by a Penny, Revenues Miss the Mark - Analyst Blog
Feb 20 / Zacks.com
Medtronic's VenaSeal Wins FDA Nod for Vericose Veins Cure - Analyst Blog
Feb 26 / Zacks.com
Boston Scientific Settles $7.2B J&J Suit for $600M, Stock Up - Analyst Blog
Feb 19 / Zacks.com
Fresenius Medical Care (FMS) Tops Q4 Earnings, Revenues - Analyst Blog
Feb 26 / Zacks.com
Boston Scientific (BSX) Shows Strength: Stock Up 12.4% - Tale of the Tape
Feb 19 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account